---
title: "Linical Reports Decline in Financial Performance for 2024"
date: "2025-02-14 16:10:58"
summary: "Maximize Your Portfolio with Data Driven Insights:Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions. Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart PortfolioLinical Co., Ltd. ( (JP:2183) )..."
categories:
  - "tipranks_announcements"
lang:
  - "en"
translations:
  - "en"
tags:
  - "tipranks_announcements"
menu: ""
thumbnail: "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1423187486-750x406.jpg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

### Maximize Your Portfolio with Data Driven Insights:

* Leverage the power of [TipRanks' Smart Score](https://www.tipranks.com/screener/top-smart-score-stocks), a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
* Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with  [Your Smart Portfolio](https://www.tipranks.com/smart-portfolio/holdings)

Linical Co., Ltd. ( [(JP:2183)](https://www.tipranks.com/stocks/jp:2183) ) has issued an update.

Linical Co., Ltd. reported a significant decline in its financial performance for the nine months ending December 31, 2024, with a 14% drop in net sales compared to the previous year. The company also faced operating and ordinary income losses, alongside a negative profit attributable to its owners, indicating a challenging economic environment and potentially impacting its market positioning and stakeholder confidence.

**More about Linical Co., Ltd.**

Linical Co., Ltd. is a company listed on the Tokyo Stock Exchange, focusing on providing comprehensive clinical research services. It operates in the healthcare and pharmaceutical industry, offering solutions that support the clinical development and regulatory approval processes.

**Average Trading Volume:** 48,225

**Technical Sentiment Consensus Rating:** Buy

**Current Market Cap:** Yen7.86B

Learn more about 2183 stock on [TipRanks’ Stock Analysis page](https://www.tipranks.com/stocks/jp:2183/stock-analysis).

Trending Articles:
------------------

* [Meta Hands Shareholders a 5% Dividend Hike as its Winning Streak Continues](https://www.tipranks.com/news/meta-hands-shareholders-a-5-dividend-hike-as-its-winning-streak-continues)
* [‘Don’t Jump In Before the Drop,’ Says Top Investor About BigBear.ai Stock](https://www.tipranks.com/news/dont-jump-in-before-the-drop-says-top-investor-about-bigbear-ai-stock)
* [‘Grab the Bull by the Horns,’ Says Daniel Ives About Tesla Stock](https://www.tipranks.com/news/grab-the-bull-by-the-horns-says-daniel-ives-about-tesla-stock)

[tipranks_announcements](https://www.tipranks.com/news/company-announcements/linical-reports-decline-in-financial-performance-for-2024)
